Username Password
S&P 500: 1,349.74 Change: +0.07%

THE MEDICINES COMPANY (MDCO)

Overview
Price 21.52
Price Change Today 0.00 (0.00%)
P&P rating Rating: 4
Zacks Rank 4 - SELL
Open Price $0.00
Previous Close $21.52
Daily Range $0.00 - $0.00
52-Week Range $12.33 - $22.48
Volume 0
chart
Medicines Company acquires, develops and commercializes biopharmaceutical products in late stages of development. U.S. Food and Drug Administration intends to approve its first product, Angiomax, for use in the treatment of patients with unstable angina undergoing coronary balloon angioplasty. The company is also developing Angiomax for additional potential applications for use in the treatment of ischemic heart disease, a condition which occurs when organs receive an inadequate supply of oxygen as a result of decreased blood flow.
Other Resources for MDCO
zacks.com
Commentary
Zacks Blog: Medicines Co. Settles with APP
January 24, 2012
Zacks Blog: Earnings Miss for The Medicines Co
October 31, 2011
Zacks Blog: Medicines Co. Settles with Teva
October 12, 2011
Zacks Blog: The Medicines Co Launches Argatroban
September 15, 2011
Zacks Blog: Zacks Bull and Bear of the Day Highlights: Fastenal, Morgan Stanley, The Medicines Company, Biogen Idec and Pfizer
July 29, 2011
Medicines Company acquires, develops and commercializes biopharmaceutical products in late stages of development. U.S. Food and Drug Administration intends to approve its first product, Angiomax, for use in the treatment ofpatients with unstable angina undergoing coronary balloon angioplasty. The company is also developing Angiomax for additional potential applications for use in the treatment of ischemic heart disease, a condition which occurs when organs receive an inadequate supply of oxygen as a result of decreased blood flow.
 
Brokerage Analyst Recommendations
6 Brokerage Firms Covering MDCO
 
   
Strong Buy
3
Buy
1
Hold
2
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.83
 
MDCO Ratings:BUY  SELL  HOLD
MDCO Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

20 Buy
0 Sell
 
Free Options Trader Guide
Top Buy Analysis
BUY: MDCO Rating: 4
Company: MEDICINES COMPANY (THE)
Points: 30.56
Start Price: $15.93
Start Date: 01/25/2011 12:24 PM
wallstreeter
wallstreeter
P&P Score: 0.23
Recs:
Broke out of long consolidation

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 01/24/12 Medicines Co. Settles with APP - Analyst Blog 0
Zacks_Analysts
0.00 10/12/11 Medicines Co. Settles with Teva - Analyst Blog 0
Zacks_Analysts
0.00 09/15/11 The Medicines Co Launches Argatroban - Analyst Blog 0
Zacks_Analysts
0.00 07/28/11 Medicines Co. Profits Down - Analyst Blog 0
Zacks_Analysts
0.00 05/26/11 Neutral on The Medicines Co. - Analyst Blog 0
Zacks_Analysts
0.00 02/18/11 4Q Earnings Beat for The Medicines Co. - Analyst Blog 0
Zacks_Analysts
0.00 12/09/10 Positive on The Medicines Co. - Analyst Blog 0
Zacks_Analysts
0.00 11/30/10 Trial Design Set for MDCO Candidate - Analyst Blog 0
Zacks_Analysts
0.00 10/28/10 Lower Costs Drive MDCO - Analyst Blog 0
Zacks_Analysts
0.00 10/07/10 Good News for MDCO - Analyst Blog 0
Pages: [ 1 ]  2   3  >>
Commentary
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $15.93
Points: +30.56
Created: 01/25/2011
Broke out of long consolidation

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $17.34
Points: +19.30
Created: 06/14/2011

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $17.30
Points: +18.20
Created: 06/11/2011

Comments: 0 | Comment

dmb dmb
Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $8.40
Points: +132.14
Created: 05/31/2010

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $21.10
Points: -35.05
Created: 10/08/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $23.70
Points: -12.60
Created: 08/11/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $19.15
Points: +20.43
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $23.50
Points: -0.37
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $18.57
Points: +23.94
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDICINES COMPANY (THE) (MDCO) Rating: 4
Start Price: $22.50
Points: +3.70
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
dmonnie 0.21 BUY One to Three Months 06/14/2011 $17.34 $21.52
(-1.65%)
+24.11% +4.80% +19.30
dmb 0.28 BUY One to Three Months 06/11/2011 $17.30 $21.52
(-1.65%)
+24.39% +6.20% +18.20
wallstreeter 0.23 BUY Three to Six Months 01/25/2011 $15.93 $21.52
(-1.65%)
+35.09% +4.54% +30.56 view
GreatestEver 99.53 BUY One to Three Months 05/31/2010 $8.40 $21.52
(-1.65%)
+156.04% +23.90% +132.14
OpeningBell 43.48 BUY Three to Six Months 10/08/2008 $21.10 $21.52
(-1.65%)
+1.99% +37.04% -35.05
MikkiLane 32.51 BUY One to Three Months 08/11/2008 $23.70 $21.52
(-1.65%)
-9.20% +3.40% -12.60
jacekslo 72.43 BUY Six Months to a Year 01/01/2008 $19.15 $21.52
(-1.65%)
+12.38% -8.05% +20.43
pod11 79.02 BUY Six Months to a Year 01/01/2008 $23.50 $21.52
(-1.65%)
-8.43% -8.05% -0.37
IDZACKS 31.39 BUY Six Months to a Year 01/01/2008 $18.57 $21.52
(-1.65%)
+15.89% -8.05% +23.94
Mike994 72.43 BUY Six Months to a Year 01/01/2008 $22.50 $21.52
(-1.65%)
-4.36% -8.05% +3.70
Pages: [ 1 ]  2  >>
Sponsored Links